Patent ID: 11918599
Assignee: GLIACELLTECH INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method for preventing or treating a neuroinflammatory disease, comprising a step of administering didanosine or a pharmaceutically acceptable salt thereof to a subject in need thereof,
wherein the subject has an increased level of an inflammatory cytokine in a central nervous system, and
wherein the neuroinflammatory disease is a disease caused by neuroinflammation in the central nervous system, and is selected from the group consisting of multiple sclerosis, neuroblastoma, stroke, dementia, Alzheimer's disease, cognitive impairment, memory impairment, disturbance of attention, Parkinson's disease, Lou Gehrig's disease, Huntington's disease, Creutzfeldt Jakob disease, post-traumatic stress disorder, depression, schizophrenia, neuropathic pain, and amyotrophic lateral sclerosis.